Published in Gene Therapy Weekly, September 7th, 2006
"J591 (mAb) has high affinity for prostate specific membrane antigen (PSMA) on prostate cancer (PCA) cells. We coupled polyethylene glycol-J591 (PEGylated J591) to a salicyl hydroxamic acid (SHA)-derivatized polyethylenimine (PEI)/DNA-beta gal vector to investigate the specificity and efficiency of targeting PSMA in PCA cells through encapsulation," wrote S. Moffatt and colleagues, University of Texas.
"Coupling was facilitated via the high affinity interaction between phenyl(di)boronic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.